Literature DB >> 25483349

Freund's adjuvant, NOD2 and mycobacteria.

Marcel A Behr1, Maziar Divangahi2.   

Abstract

PURPOSE: Mycobacterium tuberculosis contributed to the discovery of delayed-type hypersensitivity and cell-mediated immunity. However, the biochemical basis for the immunogenicity of the mycobacterial cell wall has until recently remained unknown. RECENT
FINDINGS: Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) responds to bacterial peptidolycan-derived muramyl dipeptide (MDP). Whereas most bacteria produce N-acetyl MDP, mycobacteria produce an unusual modified form of MDP, called N-glycolyl MDP. Disruption of N-glycolyl MDP synthesis in mycobacteria greatly diminishes the contribution of NOD2 to mycobacterial sensing. Additionally, N-glycolyl MDP is more potent and efficacious than N-acetyl MDP at inducing innate responses and T cell-mediated immunity.
SUMMARY: The sensitivity of NOD2 to the mycobacterial peptidoglycan may link the natural history of both innate and adaptive immunity to mycobacterial infection.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25483349     DOI: 10.1016/j.mib.2014.11.015

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  12 in total

1.  Identification of genes associated with susceptibility to Mycobacterium avium ssp. paratuberculosis (Map) tissue infection in Holstein cattle using gene set enrichment analysis-SNP.

Authors:  J N Kiser; M Neupane; S N White; H L Neibergs
Journal:  Mamm Genome       Date:  2017-11-28       Impact factor: 2.957

Review 2.  Targeting innate immunity for tuberculosis vaccination.

Authors:  Shabaana A Khader; Maziar Divangahi; Willem Hanekom; Philip C Hill; Markus Maeurer; Karen W Makar; Katrin D Mayer-Barber; Musa M Mhlanga; Elisa Nemes; Larry S Schlesinger; Reinout van Crevel; Raman (Krishna) Vankayalapati; Ramnik J Xavier; Mihai G Netea
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

3.  Rational design of adjuvants targeting the C-type lectin Mincle.

Authors:  Alexiane Decout; Sandro Silva-Gomes; Daniel Drocourt; Sophie Barbe; Isabelle André; Francisco J Cueto; Thierry Lioux; David Sancho; Eric Pérouzel; Alain Vercellone; Jacques Prandi; Martine Gilleron; Gérard Tiraby; Jérôme Nigou
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-21       Impact factor: 11.205

4.  The Combinations Chitosan-Pam3CSK4 and Chitosan-Monophosphoryl Lipid A: Promising Immune-Enhancing Adjuvants for Anticaries Vaccine PAc.

Authors:  Yongli Bi; Qingan Xu; Lingkai Su; Jiantao Xu; Zhongfang Liu; Ying Yang; Hua Tang; Yuhong Li; Mingwen Fan
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

5.  The influence of single nucleotide polymorphisms of NOD2 or CD14 on the risk of Mycobacterium tuberculosis diseases: a systematic review.

Authors:  Juan M Cubillos-Angulo; Catarina D Fernandes; Davi N Araújo; Cristinna A Carmo; María B Arriaga; Bruno B Andrade
Journal:  Syst Rev       Date:  2021-06-09

6.  Defining Genome-Wide Expression and Phenotypic Contextual Cues in Macrophages Generated by Granulocyte/Macrophage Colony-Stimulating Factor, Macrophage Colony-Stimulating Factor, and Heat-Killed Mycobacteria.

Authors:  Samer Bazzi; Emale El-Darzi; Tina McDowell; Helmout Modjtahedi; Satvinder Mudan; Marcel Achkar; Charles Akle; Humam Kadara; Georges M Bahr
Journal:  Front Immunol       Date:  2017-10-03       Impact factor: 7.561

Review 7.  Unravelling the networks dictating host resistance versus tolerance during pulmonary infections.

Authors:  Isabelle Meunier; Eva Kaufmann; Jeffrey Downey; Maziar Divangahi
Journal:  Cell Tissue Res       Date:  2017-02-06       Impact factor: 5.249

8.  NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice.

Authors:  Arshad Khan; Vipul K Singh; Abhishek Mishra; Emily Soudani; Pearl Bakhru; Christopher R Singh; Dekai Zhang; David H Canaday; Anjaneyulu Sheri; Seetharamaiyer Padmanabhan; Sreerupa Challa; Radhakrishnan P Iyer; Chinnaswamy Jagannath
Journal:  Front Immunol       Date:  2020-12-07       Impact factor: 7.561

9.  Mycobacterium avium subsp. paratuberculosis and microbiome profile of patients in a referral gastrointestinal diseases centre in the Sudan.

Authors:  Wisal A Elmagzoub; Sanaa M Idris; Maha Isameldin; Nassir Arabi; Abdelmonem Abdo; Mustafa Ibrahim; Md Anik Ashfaq Khan; Franziska Tanneberger; Sahar M Bakhiet; Julius B Okuni; Lonzy Ojok; Ahmed A Gameel; Ahmed Abd El Wahed; Michaël Bekaert; Mohamed E Mukhtar; Ahmad Amanzada; Kamal H Eltom; ElSagad Eltayeb
Journal:  PLoS One       Date:  2022-04-05       Impact factor: 3.240

Review 10.  BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases.

Authors:  Alok K Singh; Mihai G Netea; William R Bishai
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.